Moreover, HERG1 was found to be significantly upregulated in other types of cancer, such as hepatocellular carcinoma, bladder cancer, gastric cancer, and ovarian cancer (Fig. 1e). This evidence concerns the gene KCNH2 and urinary bladder carcinoma.